Peter Mugyenyi

Timing of Antiretroviral Therapy for HIV-1 Infection and Tuberculosis

Diane V. Havlir, Michelle A. Kendall, Prudence Ive et al. · New England Journal of Medicine · 2011 · 538 citations · Full text

Life Sciences, Immunology, Infectious Diseases +14

A Trial of Three Regimens to Prevent Tuberculosis in Ugandan Adults Infected with the Human Immunodeficiency Virus

Christopher C. Whalen, John L. Johnson, Alphonse Okwera et al. · New England Journal of Medicine · 1997 · 402 citations · Full text

Public Health, Infectious Diseases, Preventive Medicine +14

Depletion of Regulatory T Cells in HIV Infection Is Associated with Immune Activation

Mark P. Eggena, Banson Barugahare, Norman G. Jones et al. · The Journal of Immunology · 2005 · 364 citations · Full text

Life Sciences, Immunology, Infectious Diseases +17

Assessment of a pilot antiretroviral drug therapy programme in Uganda: patients' response, survival, and drug resistance

Paul J. Weidle, Samuel S. Malamba, Raymond Mwebaze et al. · The Lancet · 2002 · 314 citations

Public Health, Pharmacotherapy, Hiv Control +11

Multiple Validated Measures of Adherence Indicate High Levels of Adherence to Generic HIV Antiretroviral Therapy in a Resource-Limited Setting

Jessica H. Oyugi, Jayne Byakika-Tusiime, Edwin D. Charlebois et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes · 2004 · 281 citations

Pharmacy, Pharmacotherapy, Hiv Control +16